Aytül Noyan

Aytül Noyan

Auto-generated profile, based on publicly available information

Aytül Noyan

Division of Nephrology, Faculty of Medicine, Adana Dr. Turgut Noyan Teaching and Medical Research Center, Baskent University, Adana, Turkey

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1997 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
AAA. Anarat
A. Anarat
NDN. Duman
N. Duman
ANA. Noyan
A. Noyan
MKM. Kibar
M. Kibar
RAR. Anarat
R. Anarat

20 September 2023 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
SBSeyda Besen
Seyda Besen
YÖYasemin Özkale
Yasemin Özkale
SCSerdar Ceylaner
Serdar Ceylaner
ANAytul Noyan
Aytul Noyan
IEIlknur Erol
Ilknur Erol

10 August 2023 in European Journal of Therapeutics
Verified
Journal Article
Open access
PDF file
BABegüm Avcı
Begüm Avcı
GPGönül Parmaksız
Gönül Parmaksız
FŞFeride Şahin
Feride Şahin
ANAytül Noyan
Aytül Noyan
Objective: It is unclear whether exon 2 mutations are variations or a mutations that causes the disease. This study aimed to evaluate the clinical features and prognosis exon 2 mutations in Familial Mediterranean Fever. Methods: The clinical features, disease severity and prognosis of all patients with at least one exon 2 mutations were evaluated retrospectively. These data were compared seperately for homozygous (Group 1), heterozygous (Group 2), compound heterozygous (Group 3), and complex alleles (Group 4), and the data were compared by grouping patients into those with and without exon 10 mutations. Results: There were a total of 119 patients with exon 2 mutations, including 11.7% in Group 1, 36.1% in Group 2, 21.8% in Group 3, and 30.2% in Group 4 were similar in terms of demographic data, clinical characteristics, and disease course. When compared patients with exon 10 mutations (+) to those with exon 10 mutations (-), the exon 10 mutations (+) group had a higher presence of chest pain (100%, p=0.02) and a significantly higher mean Pras severity score (6.66±1.87, 6.01±1.40; p=0.02). Additionally, a higher number of patients with exon 10 mutation (-) achieved remission with treatment (76 (67.9%), 36 (32.1%); p=0.03). Conclusion: Exon 2 mutations have a milder course and higher remission rates but they should be considered as Familial Mediterranean Fever disease because of their similar clinical presentation and response to colchicine treatment with exon 10 mutations. Early treatment and close follow-up should be performed.

1 January 1995 in Nephron
Verified
Journal Article
Closed access
PDF file
ANAytül Noyan
Aytül Noyan
AAAli Anarat
Ali Anarat
ITİlHan Tuncer
İlHan Tuncer
GGGülfiliz Gönlüşen
Gülfiliz Gönlüşen
SPSait Polat
Sait Polat
The efficacy and side effects of the oral administration of cyclosporin A (Cyc-A) were investigated in 13 children with the nephrotic syndrome. Two of these children were steroid-dependent, 9 were resistant to steroids, and 2 displayed frequent relapses. The diagnosis of 6 patients was mesangioproliferative glomerulonephritis (MezPGN), of another 6 mesangiocapillary glomerulonephritis, and of 1 minimal change disease. Cyc-A was administered for 6 months at a dosage of 7 mg/kg/day with continual monitoring of the serum levels. At the end of the treatment period, 7 of the patients (53.8%) had a total remission, 5 (38.4%) a partial remission, and 1 (7.8%) did not respond to treatment. While total remission was achieved in 4 patients who had responded well to steroids, this was true for only 3 (33.3%) of the 9 patients who had not benefited from steroids. The effects and side effects of Cyc-A on histopathological morphology were also investigated by means of posttreatment biopsies. While histopathological improvement was seen in 3 patients with MezPGN, there was evidence of deterioration in 1 patient with MLH.

1 January 2018 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
AAAlev Arslan
Alev Arslan
OKOsman Küçükosmanoğlu
Osman Küçükosmanoğlu
ZNZekiye Aytül Noyan
Zekiye Aytül Noyan
NÖNazan Özbarlas
Nazan Özbarlas
Purpose: The aim of the study was to evaluate cardiac functions before and after hemodialysis in children with chronical renal failure. Materials and Methods: The study comprised 24 children undergoing hemodialysis more then six months. Conventional and tissue Doppler echocardiography was performed, NT-proBNP levels were measured before and after hemodialysis. Echocardiographic results were compared regard to hydration status which measured with body composition monitor and hypotension event during dialysis. Results: Myocardial performance indices which gained with tissue Doppler echo were high in 22 patient. Mitral E/A ratio significantly decreased after hemodialysis. NT-proBNP levels were high but no difference was determined after dialysis. Nine patient experienced hypotension but nonsignificant difference was detected regarding echocardiographic findings and NT-proBNP levels. Conclusion: Diastolic dysfunction is frequent in chronical renal failure. Tissue Doppler echocardiography and myocardial performance index supply a more proper evaluation of global and regional cardiac function in chronical renal failure due to less hydration affectability. NT-proBNP should be monitored for cardiac dysfunction in chronical renal failure. Body composition monitor should be used in children for setting the ultrafiltration volume.

1 March 2020 in Turkish Journal of Child and Adolescent Mental Health
Verified
Journal Article
Closed access
MKMeryem Özlem Kütük
Meryem Özlem Kütük
GAGülen Güler Aksu
Gülen Güler Aksu
NANihal Aktaş
Nihal Aktaş
EIEmine İnCe
Emine İnCe
ŞKŞenay Kekeç
Şenay Kekeç
ATAli Evren Tufan
Ali Evren Tufan